Bringing in voices from some of the most senior industry and scientific thought leaders from Eisai, Novimmune, Immunocore, Bayer, Biogen, Johnson and Johnson, Novartis, Roche and FNIH, Oxford Global proudly presents the 12th Annual Biomarkers Congress in discussing the latest areas in Biomarkers in Discovery and Validation, Precision Medicine, Diagnostics development and Clinical Development.
The congress will be held on 21-22 February 2017, Manchester, UK.
Our renowned biomarkers congress showcases world-class speakers discussing key innovations of biomarker research in discovery and development, companion diagnostics, data management and analytics, innovative biology, precision medicine and clinical biomarkers.
This year, the featured focus is on Oncology, Immune-oncology, Neurological, Cardiovascular, Inflammatory, Infectious & Rare Diseases.
Download the conference agenda here.
Alternatively contact Danielle Dalby on +44 1865 248455
Free Pre Congress Webinars...
Driving Precision Medicine and Advancing Clinical Data
Register for free today
Exosome Biomarkers and Diagnostics Development
Register for free today
Initiatives and Projects of FNIH and The Global Biomarkers Consortium
Register for free today - d.dalby@oxfordglobal.co.uk